Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 183 entries
View as:

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Phase: N/A Priority: Normal
NCT ID: NCT04521296 Org: User:
Start: 09/11/20 End: 03/18/22 Due: 03/18/23

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Phase: N/A Priority: Normal
NCT ID: NCT05378360 Org: User:
Start: 05/02/22 End: 12/28/23 Due: 12/28/24

A Multiple Dose Study of DWP05195 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01094834 Org: User:
Start: 04/30/10 End: - Due: -

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

Phase: N/A Priority: Normal
NCT ID: NCT04541485 Org: User:
Start: 12/04/20 End: 03/23/21 Due: 03/23/22

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031

Phase: N/A Priority: Normal
NCT ID: NCT01522586 Org: User:
Start: 01/31/12 End: 12/31/13 Due: 12/31/14

Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT04341428 Org: User:
Start: 07/02/20 End: 12/30/21 Due: 12/30/22

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05643508 Org: User:
Start: 12/31/22 End: 03/31/24 Due: 03/31/25

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT04632862 Org: User:
Start: 11/11/20 End: 11/25/21 Due: 11/25/22

The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05607589 Org: User:
Start: 10/31/22 End: 03/08/24 Due: 03/08/25

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03574285 Org: User:
Start: 05/31/18 End: 10/12/18 Due: 10/12/19

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02648906 Org: User:
Start: 07/31/15 End: - Due: -

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02622685 Org: User:
Start: 05/31/15 End: 02/29/16 Due: 02/28/17

Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04393597 Org: User:
Start: 05/28/20 End: 11/30/20 Due: 11/30/21

Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Phase: N/A Priority: Normal
NCT ID: NCT05614752 Org: User:
Start: 07/06/22 End: 11/08/24 Due: 11/08/25

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Phase: N/A Priority: Normal
NCT ID: NCT02947620 Org: User:
Start: 08/31/15 End: 02/27/17 Due: 02/27/18

Clinical Study for Patients With Hypertension Associated With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT01764295 Org: User:
Start: 09/30/12 End: 07/31/13 Due: 07/31/14

To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04524052 Org: User:
Start: 08/31/20 End: 12/31/20 Due: 12/31/21

Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06119958 Org: User:
Start: 10/27/23 End: 12/31/23 Due: 12/31/24

Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01653314 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05226533 Org: User:
Start: 03/31/22 End: 12/21/22 Due: 12/21/23

Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Phase: N/A Priority: Normal
NCT ID: NCT03224117 Org: User:
Start: 10/26/17 End: 06/29/18 Due: 06/29/19

Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05614765 Org: User:
Start: 07/08/22 End: 06/30/25 Due: 06/30/26

A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06736587 Org: User:
Start: 12/10/24 End: 06/30/26 Due: 06/30/27

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05954338 Org: User:
Start: 08/01/23 End: 12/01/23 Due: 12/01/24

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03005223 Org: User:
Start: 01/04/17 End: 06/30/17 Due: 06/30/18